SCHEMBL18220152

SCHEMBL18220152

COCCNS(=O)(=O)/C(C#N)=C(\C)c1ccc(-c2ccc3cc(NCCN4CCOCC4)ccc3c2)o1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.40
KDM4E B2RXH2 5/20 0.40
HPGD P15428 5/20 0.40
GAA P10253 4/20 0.40
POLB P06746 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
GLA P06280 1/20 0.36
HSD17B10 Q99714 4/20 0.36
SCN9A Q15858 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
MAPK1 P28482 4/20 0.36
MAPT P10636 3/20 0.36
USP2 O75604 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
CYP3A4 P08684 1/20 0.36
SYK P43405 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25609363 0.91 POLB (0.38) ALDH1A1KDM4EHPGDGAAPOLB
SCHEMBL18220262 0.88 ALDH1A1 (0.38) ALDH1A1KDM4EHPGDGAAPOLB
SCHEMBL17120670 0.88 ALDH1A1 (0.38) ALDH1A1KDM4EHPGDGAAPOLB
SCHEMBL18220005 0.87 CYP2C19 (0.41) ALDH1A1KDM4EGAAPOLBNPSR1
SCHEMBL18220202 0.86 CA1 (0.37) ALDH1A1KDM4EGAAPOLBNPSR1
SCHEMBL18221625 0.86 ALDH1A1 (0.35) ALDH1A1KDM4EHPGDGAAPOLB
SCHEMBL18220151 0.85 APP (0.44) ALDH1A1KDM4EHPGDGAAMAPT
SCHEMBL18220180 0.85 WNT3A (0.38) ALDH1A1KDM4EGAAPOLBNPSR1
SCHEMBL18220135 0.85 ALDH1A1 (0.49) ALDH1A1KDM4EHPGDGAAPOLB
SCHEMBL18220351 0.85 ALDH1A1 (0.35) ALDH1A1KDM4EHPGDGAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240208916-A1 AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME Amydis, Inc. 2024-06-27 US disclosed
US-11718596-B2 Amyloid targeting agents and methods of using the same THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-08-08 US disclosed
US-20210369873-A1 COMPOSITIONS AND METHODS FOR DETECTION OF TRAUMATIC BRAIN INJURY Amydis, Inc. 2021-12-02 US disclosed
US-10934264-B2 Amyloid targeting agents and methods of using the same THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-03-02 US disclosed
US-20200123118-A1 AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2020-04-23 US disclosed
US-10005745-B2 Amyloid targeting agents and methods of using the same THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2018-06-26 US disclosed
US-20170248616-A1 IN VITRO COMPOSITIONS COMPRISING HUMAN SAMPLE AND AMYLOID TARGETING AGENT Amydis, Inc. 2017-08-31 US disclosed
US-20160326126-A1 AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME Amydis, Inc. 2016-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11718596-B2 Amyloid targeting agents and methods of using the same APP, CRYAA, APBA1 ALDH1A1 4151/4885KDM4E 4807/4885HPGD 4282/4885
US-20200123118-A1 AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME APP, CRYAA, APBA1 ALDH1A1 4151/4885KDM4E 4807/4885HPGD 4282/4885
US-20210369873-A1 COMPOSITIONS AND METHODS FOR DETECTION OF TRAUMATIC BRAIN INJURY S100B, FABP7, CRYAB ALDH1A1 4102/4885KDM4E 4796/4885HPGD 3606/4885
US-20240208916-A1 AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME APP, CRYAA, APBA1 ALDH1A1 4151/4885KDM4E 4807/4885HPGD 4282/4885
US-20160326126-A1 AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME APP, APBA1, CRYAA ALDH1A1 4226/4885KDM4E 4804/4885HPGD 4311/4885
US-10934264-B2 Amyloid targeting agents and methods of using the same APP, CRYAA, APBA1 ALDH1A1 4151/4885KDM4E 4807/4885HPGD 4282/4885
US-10005745-B2 Amyloid targeting agents and methods of using the same APP, APBA1, CRYAA ALDH1A1 4226/4885KDM4E 4804/4885HPGD 4311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.